Efficacy and Safety of Ribociclib Plus Endocrine Therapy Versus Endocrine Therapy Alone in HR-Positive/HER2-Negative Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Saved in:
| Title: | Efficacy and Safety of Ribociclib Plus Endocrine Therapy Versus Endocrine Therapy Alone in HR-Positive/HER2-Negative Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. |
|---|---|
| Authors: | Dhungana, Reechashree1 (AUTHOR) reecha651@gmail.com, Prasai, Parikshit2 (AUTHOR), Paudel, Bishal3 (AUTHOR), Ranabhat, Kamal4,5 (AUTHOR), Sapkota, Simit6 (AUTHOR), Shrestha, Sunil7,8 (AUTHOR) |
| Source: | Clinical Medicine Insights: Oncology. 12/18/2025, Vol. 19, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 11795549 |
|---|---|
| DOI: | 10.1177/11795549251402955 |
